We are live on ! Find out more
BIOA

BioAge Labs
BIOA

94 hedge funds and large institutions have $125M invested in BioAge Labs in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

60% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 20

46% more capital invested

Capital invested by funds: $85.6M → $125M (+$39.4M)

13% more funds holding

Funds holding: 83 → 94 (+11)

1.51% more ownership

Funds ownership: 57.79% → 59.3% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

96% less call options, than puts

Call options by funds: $70K | Put options by funds: $1.75M

Holders
94
Holders Change
+11
Holders Change %
+13.25%
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
32
Reduced
20
Closed
3
Calls
$70K
Puts
$1.75M
Net Calls
-$1.68M
Net Calls Change
-$423K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.27M
2
Los Angeles Capital Management
Los Angeles Capital Management
California
+$566K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$512K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$439K
5
Charles Schwab
Charles Schwab
California
+$333K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$826K
2
O
OrbiMed
New York
-$614K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$283K
4
ACM
ADAR1 Capital Management
Texas
-$267K
5
Marshall Wace
Marshall Wace
United Kingdom
-$246K
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
76
Amalgamated Bank
New York
$2K – – –
PA
77
Parallel Advisors
California
$1.76K – – –
Citigroup
78
Citigroup
New York
$1.62K -$51K -10,882 -98%
TWC
79
TD Waterhouse Canada
Ontario, Canada
$1.51K – – –
Nisa Investment Advisors
80
Nisa Investment Advisors
Missouri
$1.39K – – –
Federated Hermes
81
Federated Hermes
Pennsylvania
$1.08K -$3.81K -814 -82%
CPG
82
Cornerstone Planning Group
New Jersey
$725 +$468 +100 New
FFO
83
Fortitude Family Office
Arizona
$706 +$562 +120 New
EWA
84
EverSource Wealth Advisors
Alabama
$647 +$473 +101 +1,122%
FFA
85
Farther Finance Advisors
California
$594 +$473 +101 New
TWD
86
True Wealth Design
Ohio
$471 – – –
EP
87
Essential Partners
California
$335 +$61 +13 +30%
RIL
88
Rothschild Investment LLC
Illinois
$323 – – –
National Bank of Canada
89
National Bank of Canada
Quebec, Canada
$264 -$2.34K -500 -92%
PS
90
Principal Securities
Iowa
$241 +$192 +41 New
CA
91
Clearstead Advisors
Ohio
$106 – – –
ASN
92
Advisory Services Network
Georgia
$76 +$61 +13 New
IA
93
IFP Advisors
Florida
$12 +$9 +2 New
CF
94
Cantor Fitzgerald
New York
– -$826K -200,000 Closed
JFG
95
Jefferies Financial Group
New York
– -$207K -50,000 Closed
VF
96
Virtu Financial
New York
– -$62K -14,911 Closed
1 2 3
4

BIOA Hedge Fund Activity: Q3 2025 in Review

94 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q3 2025, worth a combined $125M — up 46% from $85.6M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BIOA positions and 3 closed out — a net gain of 11 holders — while 32 added to existing stakes and 20 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.27M. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $826K sold.

  • 94 institutional investors held BioAge Labs (BIOA) as of Q3 2025, up from 83 in Q2 2025.
  • Funds reported $125M of BioAge Labs stock for Q3 2025, up 46% quarter-over-quarter.
  • 14 funds opened new BioAge Labs positions in Q3 2025 and 3 closed out, a net change of +11 holders.
  • The largest BioAge Labs buyer in Q3 2025 was Millennium Management, an estimated $1.27M added.
  • The largest BioAge Labs seller in Q3 2025 was Cantor Fitzgerald, an estimated $826K sold.

Based on aggregated 13F filings for Q3 2025.